John M. Zajecka, MD

Original Research

Long-Term Efficacy, Safety, and Tolerability of l-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors: A 12-Month, Open-Label Study Following a Placebo-Controlled #05#

May 25, 2016

Original Research

Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs

December 23, 2015

Original Research

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

April 15, 2014

Supplement Article

Residual Symptoms and Relapse: Mood, Cognitive Symptoms, and Sleep Disturbances

October 29, 2013

Article

Residual Symptoms and Relapse: Mood, Cognitive Symptoms, and Sleep Disturbances

October 15, 2013

Original Research

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

December 15, 2012

Educational Activity

Evidence for the Use of <span style="font-variant:small-caps;">l</span>-Methylfolate Combined With Antidepressants in MDD

August 15, 2011

Letter to the Editor

Oral Divalproex Sodium Loading for Adolescent Outpatients With Acute Mania/Hypomania: A Report of 2 Cases

June 30, 2008

Article

Augmentation Strategies to Increase Antidepressant Tolerability

August 15, 2007

Original Research

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

August 15, 2007

Original Research

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

July 16, 2007

Educational Activity

Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

March 15, 2007